XML 25 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Basis of presentation
9 Months Ended
Mar. 31, 2013
Basis of presentation  
Basis of presentation

1.         Basis of presentation — The unaudited consolidated interim financial statements included herein have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. These financial statements include all adjustments, consisting only of those of a normal recurring nature, which, in the opinion of management, are necessary to present fairly the results of the interim periods presented and should be read in conjunction with the consolidated financial statements and notes thereto in our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.  The results of operations for the three-and nine-month periods ended March 31, 2013 are not necessarily indicative of the results to be expected for the full year ending June 30, 2013.

 

The balance sheet at June 30, 2012 has been derived from the audited consolidated financial statements at that date but does not include all of the information and notes required by U.S. GAAP for complete financial statements. For further information, refer to the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.  We operate our business as a single operating segment.

 

In the second quarter of fiscal 2013, the Company made a strategic decision to accelerate the sell off of certain inventory by the end of the 2013 calendar year. In connection with this decision, the Company recorded a pre-tax $41.8 million inventory write-down in cost of goods sales. This write-down reduced net income for the nine months ended March 31, 2013 by $26.3 million or $0.62 per diluted share.